DMT is N,N-dimethyltryptamine, a compound causing brief and intense psychedelic experiences. Scientists are beginning to ...

a severe form of the disease that emerges in infancy. Having these treatment options has drastically improved outcomes for ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry ...

- This is Dermata's first allowed U.S. patent application for DMT310, using its Spongilla technology to topically treat acne - - Dermata recently completed enrollment in its DMT310 Phase 3 STAR-1 ...

In response to this global need for more universal and broadly deliverable, frontline treatments, Algernon Pharmaceuticals ...